Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A prospective, randomized, parallel-group study to assess the effects on ovarian activity of ellaOne (ulipristal acetate 30 mg single dose) taken after three consecutive days of missed combined oral contraceptive pills

Next Previous
X
Search
Trial Profile

A prospective, randomized, parallel-group study to assess the effects on ovarian activity of ellaOne (ulipristal acetate 30 mg single dose) taken after three consecutive days of missed combined oral contraceptive pills

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Jun 2020

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ulipristal (Primary) ; Ethinylestradiol; Ethinylestradiol/levonorgestrel
  • Indications Pregnancy
  • Focus Therapeutic Use
  • Sponsors HRA Pharma

    • Most Recent Events

    • 28 May 2020 Primary endpoint (Ovarian activity score, Occurrence of ovulation with risk of pregnancy, Time to ovulation with risk of pregnancy) has been met, according to Results published in the Contraception
    • 28 May 2020 Results published in the Contraception
    • 27 Jun 2018 Status changed from recruiting to completed.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top